Bio-batch size for suspensions [Regulatives / Guidelines]

posted by sireen – Jordan, 2015-08-24 07:20 (3462 d 21:19 ago) – Posting: # 15325
Views: 2,612

Dear All,

The emea guideline for bioequivalence, 2010, states that the test product (for oral solid forms) should usually originate from a batch of at least 1/10 of production scale or 100,000 units, whichever is greater, unless otherwise justified.....What about oral suspensions and powder for suspension, packaged in multiple dose containers....what is the requested Bio-batch size?

I'll appreciate if someone could send me any references on this subject.

Many thanks in advance!
Sireen

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
34 visitors (0 registered, 34 guests [including 8 identified bots]).
Forum time: 03:39 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5